NL8702320A - Onverzadigde aromatische peroxiden en toepassing daarvan in de geneeskunde en de cosmetica. - Google Patents

Onverzadigde aromatische peroxiden en toepassing daarvan in de geneeskunde en de cosmetica. Download PDF

Info

Publication number: NL8702320A
Authority: NL; Netherlands
Prior art keywords: group; peroxide; peroxides; composition according; carbon atoms
Prior art date: 1986-09-30

Application number

NL8702320A

Other languages

English (en)

Dutch (nl)

Original Assignee

Oreal

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-09-30

Filing date

1987-09-29

Publication date

1988-04-18

1987-09-29 Application filed by Oreal filed Critical Oreal

1988-04-18 Publication of NL8702320A publication Critical patent/NL8702320A/nl

Links

150000002978 peroxides Chemical class 0.000 title claims description 31
239000002537 cosmetic Substances 0.000 title claims description 5
-1 p-trifluoromethylphenyl Chemical group 0.000 claims description 24
239000000203 mixture Substances 0.000 claims description 22
125000004432 carbon atom Chemical group C* 0.000 claims description 8
239000000839 emulsion Substances 0.000 claims description 6
125000003118 aryl group Chemical group 0.000 claims description 5
ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 claims description 4
239000003242 anti bacterial agent Substances 0.000 claims description 4
239000003795 chemical substances by application Substances 0.000 claims description 4
125000000392 cycloalkenyl group Chemical group 0.000 claims description 4
239000000843 powder Substances 0.000 claims description 4
239000000126 substance Substances 0.000 claims description 4
239000000975 dye Substances 0.000 claims description 3
150000002148 esters Chemical class 0.000 claims description 3
239000002674 ointment Substances 0.000 claims description 3
239000002304 perfume Substances 0.000 claims description 3
239000003755 preservative agent Substances 0.000 claims description 3
238000011200 topical administration Methods 0.000 claims description 3
125000006025 1-methyl-1-butenyl group Chemical group 0.000 claims description 2
125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 claims description 2
125000006043 5-hexenyl group Chemical group 0.000 claims description 2
239000004677 Nylon Substances 0.000 claims description 2
239000004698 Polyethylene Substances 0.000 claims description 2
229920002472 Starch Polymers 0.000 claims description 2
125000002252 acyl group Chemical group 0.000 claims description 2
125000003342 alkenyl group Chemical group 0.000 claims description 2
239000002260 anti-inflammatory agent Substances 0.000 claims description 2
229940121363 anti-inflammatory agent Drugs 0.000 claims description 2
230000003115 biocidal effect Effects 0.000 claims description 2
229960002227 clindamycin Drugs 0.000 claims description 2
KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 claims description 2
239000003581 cosmetic carrier Substances 0.000 claims description 2
125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 claims description 2
125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 claims description 2
239000003937 drug carrier Substances 0.000 claims description 2
229960003276 erythromycin Drugs 0.000 claims description 2
125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims description 2
239000000945 filler Substances 0.000 claims description 2
125000005843 halogen group Chemical group 0.000 claims description 2
125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
239000006210 lotion Substances 0.000 claims description 2
125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 2
229920001778 nylon Polymers 0.000 claims description 2
125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims description 2
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
239000000049 pigment Substances 0.000 claims description 2
229920000573 polyethylene Polymers 0.000 claims description 2
150000003839 salts Chemical class 0.000 claims description 2
239000002904 solvent Substances 0.000 claims description 2
239000003381 stabilizer Substances 0.000 claims description 2
239000008107 starch Substances 0.000 claims description 2
235000019698 starch Nutrition 0.000 claims description 2
230000000475 sunscreen effect Effects 0.000 claims description 2
239000000516 sunscreening agent Substances 0.000 claims description 2
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 2
239000000080 wetting agent Substances 0.000 claims description 2
125000004204 2-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C([H])=C1[H] 0.000 claims 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
239000003429 antifungal agent Substances 0.000 claims 1
229940121375 antifungal agent Drugs 0.000 claims 1
229910052799 carbon Inorganic materials 0.000 claims 1
239000000463 material Substances 0.000 claims 1
239000003352 sequestering agent Substances 0.000 claims 1
239000004094 surface-active agent Substances 0.000 claims 1
239000000454 talc Substances 0.000 claims 1
229910052623 talc Inorganic materials 0.000 claims 1
239000002562 thickening agent Substances 0.000 claims 1
206010000496 acne Diseases 0.000 description 11
239000003921 oil Substances 0.000 description 10
208000002874 Acne Vulgaris Diseases 0.000 description 9
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
150000001875 compounds Chemical class 0.000 description 9
235000019198 oils Nutrition 0.000 description 9
210000003491 skin Anatomy 0.000 description 8
230000000694 effects Effects 0.000 description 7
239000012071 phase Substances 0.000 description 7
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
239000004342 Benzoyl peroxide Substances 0.000 description 5
OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 5
235000019400 benzoyl peroxide Nutrition 0.000 description 5
239000003925 fat Substances 0.000 description 5
235000019197 fats Nutrition 0.000 description 5
238000002360 preparation method Methods 0.000 description 5
210000002374 sebum Anatomy 0.000 description 5
RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 4
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
238000002835 absorbance Methods 0.000 description 4
239000012933 diacyl peroxide Substances 0.000 description 4
239000003480 eluent Substances 0.000 description 4
BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 4
238000002329 infrared spectrum Methods 0.000 description 4
230000001530 keratinolytic effect Effects 0.000 description 4
229920001223 polyethylene glycol Polymers 0.000 description 4
239000001993 wax Substances 0.000 description 4
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
229940124091 Keratolytic Drugs 0.000 description 3
239000002202 Polyethylene glycol Substances 0.000 description 3
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
208000027418 Wounds and injury Diseases 0.000 description 3
238000010521 absorption reaction Methods 0.000 description 3
239000000058 anti acne agent Substances 0.000 description 3
230000003255 anti-acne Effects 0.000 description 3
229940124340 antiacne agent Drugs 0.000 description 3
230000003385 bacteriostatic effect Effects 0.000 description 3
229960000541 cetyl alcohol Drugs 0.000 description 3
239000013065 commercial product Substances 0.000 description 3
238000001704 evaporation Methods 0.000 description 3
230000008020 evaporation Effects 0.000 description 3
239000000499 gel Substances 0.000 description 3
229940100242 glycol stearate Drugs 0.000 description 3
210000004209 hair Anatomy 0.000 description 3
UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 3
238000000034 method Methods 0.000 description 3
238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 3
208000017520 skin disease Diseases 0.000 description 3
YNJSNEKCXVFDKW-UHFFFAOYSA-N 3-(5-amino-1h-indol-3-yl)-2-azaniumylpropanoate Chemical compound C1=C(N)C=C2C(CC(N)C(O)=O)=CNC2=C1 YNJSNEKCXVFDKW-UHFFFAOYSA-N 0.000 description 2
241000894006 Bacteria Species 0.000 description 2
241000186427 Cutibacterium acnes Species 0.000 description 2
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
239000004166 Lanolin Substances 0.000 description 2
CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
229940088710 antibiotic agent Drugs 0.000 description 2
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
230000008859 change Effects 0.000 description 2
230000002995 comedolytic effect Effects 0.000 description 2
239000006071 cream Substances 0.000 description 2
239000010779 crude oil Substances 0.000 description 2
230000006378 damage Effects 0.000 description 2
238000001035 drying Methods 0.000 description 2
ZDLPPKSPYPXRNP-UHFFFAOYSA-N ethenylperoxyethene Chemical compound C=COOC=C ZDLPPKSPYPXRNP-UHFFFAOYSA-N 0.000 description 2
XIRNKXNNONJFQO-UHFFFAOYSA-N ethyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC XIRNKXNNONJFQO-UHFFFAOYSA-N 0.000 description 2
210000003780 hair follicle Anatomy 0.000 description 2
229920006007 hydrogenated polyisobutylene Polymers 0.000 description 2
239000011261 inert gas Substances 0.000 description 2
208000014674 injury Diseases 0.000 description 2
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
230000003780 keratinization Effects 0.000 description 2
229940039717 lanolin Drugs 0.000 description 2
235000019388 lanolin Nutrition 0.000 description 2
239000000314 lubricant Substances 0.000 description 2
238000005461 lubrication Methods 0.000 description 2
230000007935 neutral effect Effects 0.000 description 2
WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
239000012074 organic phase Substances 0.000 description 2
239000001301 oxygen Substances 0.000 description 2
229910052760 oxygen Inorganic materials 0.000 description 2
SSZBUIDZHHWXNJ-UHFFFAOYSA-N palmityl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCC SSZBUIDZHHWXNJ-UHFFFAOYSA-N 0.000 description 2
230000008569 process Effects 0.000 description 2
229940055019 propionibacterium acne Drugs 0.000 description 2
YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
210000001732 sebaceous gland Anatomy 0.000 description 2
239000000377 silicon dioxide Substances 0.000 description 2
229910052938 sodium sulfate Inorganic materials 0.000 description 2
235000011152 sodium sulphate Nutrition 0.000 description 2
PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
MZFGYVZYLMNXGL-UHFFFAOYSA-N undec-10-enoyl chloride Chemical compound ClC(=O)CCCCCCCCC=C MZFGYVZYLMNXGL-UHFFFAOYSA-N 0.000 description 2
DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
MLQBTMWHIOYKKC-KTKRTIGZSA-N (z)-octadec-9-enoyl chloride Chemical compound CCCCCCCC\C=C/CCCCCCCC(Cl)=O MLQBTMWHIOYKKC-KTKRTIGZSA-N 0.000 description 1
GYSCBCSGKXNZRH-UHFFFAOYSA-N 1-benzothiophene-2-carboxamide Chemical compound C1=CC=C2SC(C(=O)N)=CC2=C1 GYSCBCSGKXNZRH-UHFFFAOYSA-N 0.000 description 1
125000004201 2,4-dichlorophenyl group Chemical group [H]C1=C([H])C(*)=C(Cl)C([H])=C1Cl 0.000 description 1
JVTIXNMXDLQEJE-UHFFFAOYSA-N 2-decanoyloxypropyl decanoate 2-octanoyloxypropyl octanoate Chemical compound C(CCCCCCC)(=O)OCC(C)OC(CCCCCCC)=O.C(=O)(CCCCCCCCC)OCC(C)OC(=O)CCCCCCCCC JVTIXNMXDLQEJE-UHFFFAOYSA-N 0.000 description 1
NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 1
125000006027 3-methyl-1-butenyl group Chemical group 0.000 description 1
125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 1
208000020154 Acnes Diseases 0.000 description 1
NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
244000144725 Amygdalus communis Species 0.000 description 1
235000011437 Amygdalus communis Nutrition 0.000 description 1
BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
GHVNFZFCNZKVNT-UHFFFAOYSA-N Decanoic acid Natural products CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 1
206010048768 Dermatosis Diseases 0.000 description 1
QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical group C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
206010020649 Hyperkeratosis Diseases 0.000 description 1
206010020751 Hypersensitivity Diseases 0.000 description 1
OJMMVQQUTAEWLP-UHFFFAOYSA-N Lincomycin Natural products CN1CC(CCC)CC1C(=O)NC(C(C)O)C1C(O)C(O)C(O)C(SC)O1 OJMMVQQUTAEWLP-UHFFFAOYSA-N 0.000 description 1
239000005662 Paraffin oil Substances 0.000 description 1
235000019483 Peanut oil Nutrition 0.000 description 1
102000035195 Peptidases Human genes 0.000 description 1
108091005804 Peptidases Proteins 0.000 description 1
229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
239000004365 Protease Substances 0.000 description 1
208000003251 Pruritus Diseases 0.000 description 1
206010037211 Psychomotor hyperactivity Diseases 0.000 description 1
235000019484 Rapeseed oil Nutrition 0.000 description 1
244000166071 Shorea robusta Species 0.000 description 1
235000015076 Shorea robusta Nutrition 0.000 description 1
229920002125 Sokalan® Polymers 0.000 description 1
235000019486 Sunflower oil Nutrition 0.000 description 1
235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
241001135917 Vitellaria paradoxa Species 0.000 description 1
206010052428 Wound Diseases 0.000 description 1
230000009471 action Effects 0.000 description 1
208000026935 allergic disease Diseases 0.000 description 1
239000008168 almond oil Substances 0.000 description 1
OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
229940031955 anhydrous lanolin Drugs 0.000 description 1
239000010775 animal oil Substances 0.000 description 1
229940031012 anti-acne preparations Drugs 0.000 description 1
230000000843 anti-fungal effect Effects 0.000 description 1
235000021302 avocado oil Nutrition 0.000 description 1
239000008163 avocado oil Substances 0.000 description 1
230000001580 bacterial effect Effects 0.000 description 1
235000013871 bee wax Nutrition 0.000 description 1
239000012166 beeswax Substances 0.000 description 1
WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
VBICKXHEKHSIBG-UHFFFAOYSA-N beta-monoglyceryl stearate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
239000004204 candelilla wax Substances 0.000 description 1
235000013868 candelilla wax Nutrition 0.000 description 1
229940073532 candelilla wax Drugs 0.000 description 1
239000004203 carnauba wax Substances 0.000 description 1
235000013869 carnauba wax Nutrition 0.000 description 1
239000000969 carrier Substances 0.000 description 1
239000004359 castor oil Substances 0.000 description 1
235000019438 castor oil Nutrition 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
229940048851 cetyl ricinoleate Drugs 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
235000005687 corn oil Nutrition 0.000 description 1
239000002285 corn oil Substances 0.000 description 1
230000018109 developmental process Effects 0.000 description 1
239000003814 drug Substances 0.000 description 1
229940067592 ethyl palmitate Drugs 0.000 description 1
150000002191 fatty alcohols Chemical class 0.000 description 1
238000009472 formulation Methods 0.000 description 1
238000001879 gelation Methods 0.000 description 1
239000003349 gelling agent Substances 0.000 description 1
210000004907 gland Anatomy 0.000 description 1
YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
239000008169 grapeseed oil Substances 0.000 description 1
IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
OSCNKYWIVFHQMF-UHFFFAOYSA-N hept-6-enoyl chloride Chemical compound ClC(=O)CCCCC=C OSCNKYWIVFHQMF-UHFFFAOYSA-N 0.000 description 1
XAMHKORMKJIEFW-AYTKPMRMSA-N hexadecyl (z,12r)-12-hydroxyoctadec-9-enoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC\C=C/C[C@H](O)CCCCCC XAMHKORMKJIEFW-AYTKPMRMSA-N 0.000 description 1
230000003054 hormonal effect Effects 0.000 description 1
230000009610 hypersensitivity Effects 0.000 description 1
230000002757 inflammatory effect Effects 0.000 description 1
230000028709 inflammatory response Effects 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
230000007794 irritation Effects 0.000 description 1
230000007803 itching Effects 0.000 description 1
229940119170 jojoba wax Drugs 0.000 description 1
239000003410 keratolytic agent Substances 0.000 description 1
OJMMVQQUTAEWLP-KIDUDLJLSA-N lincomycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 OJMMVQQUTAEWLP-KIDUDLJLSA-N 0.000 description 1
229960005287 lincomycin Drugs 0.000 description 1
229910052943 magnesium sulfate Inorganic materials 0.000 description 1
235000019341 magnesium sulphate Nutrition 0.000 description 1
239000002480 mineral oil Substances 0.000 description 1
239000002736 nonionic surfactant Substances 0.000 description 1
238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
235000019488 nut oil Nutrition 0.000 description 1
239000010466 nut oil Substances 0.000 description 1
WKOURAYMOMBTRL-UHFFFAOYSA-N octadec-9-enoyl benzenecarboperoxoate Chemical compound CCCCCCCCC=CCCCCCCCC(=O)OOC(=O)C1=CC=CC=C1 WKOURAYMOMBTRL-UHFFFAOYSA-N 0.000 description 1
239000004006 olive oil Substances 0.000 description 1
235000008390 olive oil Nutrition 0.000 description 1
150000001451 organic peroxides Chemical class 0.000 description 1
FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
239000000312 peanut oil Substances 0.000 description 1
XCRBXWCUXJNEFX-UHFFFAOYSA-N peroxybenzoic acid Chemical class OOC(=O)C1=CC=CC=C1 XCRBXWCUXJNEFX-UHFFFAOYSA-N 0.000 description 1
235000019271 petrolatum Nutrition 0.000 description 1
230000000144 pharmacologic effect Effects 0.000 description 1
239000004584 polyacrylic acid Substances 0.000 description 1
229920000059 polyethylene glycol stearate Polymers 0.000 description 1
239000010491 poppyseed oil Substances 0.000 description 1
230000002335 preservative effect Effects 0.000 description 1
239000000047 product Substances 0.000 description 1
230000035755 proliferation Effects 0.000 description 1
239000008213 purified water Substances 0.000 description 1
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
230000009257 reactivity Effects 0.000 description 1
235000005713 safflower oil Nutrition 0.000 description 1
239000003813 safflower oil Substances 0.000 description 1
229960004889 salicylic acid Drugs 0.000 description 1
229920006395 saturated elastomer Polymers 0.000 description 1
230000028327 secretion Effects 0.000 description 1
229940057910 shea butter Drugs 0.000 description 1
229920002545 silicone oil Polymers 0.000 description 1
RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical class [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 1
159000000000 sodium salts Chemical class 0.000 description 1
FOTNEEVHXTXVFX-UHFFFAOYSA-M sodium;benzenecarboperoxoate Chemical compound [Na+].[O-]OC(=O)C1=CC=CC=C1 FOTNEEVHXTXVFX-UHFFFAOYSA-M 0.000 description 1
239000000600 sorbitol Substances 0.000 description 1
238000003756 stirring Methods 0.000 description 1
239000002600 sunflower oil Substances 0.000 description 1
239000000725 suspension Substances 0.000 description 1
OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
150000003626 triacylglycerols Chemical class 0.000 description 1
UPMYPJGSCUKJJG-UHFFFAOYSA-N undec-10-enoyl benzenecarboperoxoate Chemical compound C=CCCCCCCCCC(=O)OOC(=O)C1=CC=CC=C1 UPMYPJGSCUKJJG-UHFFFAOYSA-N 0.000 description 1
235000021122 unsaturated fatty acids Nutrition 0.000 description 1
150000004670 unsaturated fatty acids Chemical class 0.000 description 1
229940099259 vaseline Drugs 0.000 description 1
235000019871 vegetable fat Nutrition 0.000 description 1
125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
229920002554 vinyl polymer Polymers 0.000 description 1
238000005406 washing Methods 0.000 description 1
239000010497 wheat germ oil Substances 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C409/00—Peroxy compounds
- C07C409/32—Peroxy compounds the —O—O— group being bound between two >C=O groups
- C07C409/34—Peroxy compounds the —O—O— group being bound between two >C=O groups both belonging to carboxylic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/38—Percompounds, e.g. peracids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Dermatology (AREA)
Emergency Medicine (AREA)
Birds (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Cosmetics (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NL8702320A 1986-09-30 1987-09-29 Onverzadigde aromatische peroxiden en toepassing daarvan in de geneeskunde en de cosmetica. NL8702320A (nl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR8613606		1986-09-30
FR8613606A FR2604435B1 (fr)	1986-09-30	1986-09-30	Peroxydes aromatiques insatures et leur utilisation en therapeutique et cosmetique

Publications (1)

Publication Number	Publication Date
NL8702320A true NL8702320A (nl)	1988-04-18

Family

ID=9339395

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NL8702320A NL8702320A (nl)	1986-09-30	1987-09-29	Onverzadigde aromatische peroxiden en toepassing daarvan in de geneeskunde en de cosmetica.

Country Status (10)

Country	Link
US (1)	US4803228A (de)
JP (1)	JPS6391362A (de)
BE (1)	BE1004154A4 (de)
CA (1)	CA1282429C (de)
CH (1)	CH672125A5 (de)
DE (1)	DE3732839A1 (de)
FR (1)	FR2604435B1 (de)
GB (1)	GB2196339B (de)
IT (1)	IT1222771B (de)
NL (1)	NL8702320A (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2628319B1 (fr) *	1988-03-09	1990-12-07	Oreal	Compositions pharmaceutiques et cosmetiques a base de peroxyde de benzoyle et de sels d'ammonium quaternaires
US5204093A (en) *	1989-04-06	1993-04-20	Victor Steven A	Shaving cream composition for the treatment of acne vulgaris and pseudofolliculitis barbae and method of producing and using same
DE4329379C1 (de) *	1993-09-01	1995-02-16	Beiersdorf Ag	Gegen unreine Haut und milde Formen der Akne wirksame Zubereitungen mit einem Gehalt an Wollwachssäuren
US6262117B1 (en)	1999-02-18	2001-07-17	Allergan Sales, Inc.	Method and composition for treating acne
US20030091657A1 (en) *	2000-03-17	2003-05-15	Helene Chiasson	Plant acaricidal compositions and method using same
US20020026011A1 (en) *	2000-05-25	2002-02-28	Brothers Paul Douglas	Synthesis of diacyl peroxide in aprotic solvent
US20040171561A1 (en) *	2002-09-03	2004-09-02	Popp Karl F.	Topical formulations for treatment of rosacea
US20040167223A1 (en) *	2002-09-03	2004-08-26	Popp Karl F.	Topical antibacterial formulations
US20040043946A1 (en) *	2002-09-03	2004-03-04	Popp Karl F.	Topical formulations for treatment of skin disorders
US20050025817A1 (en) *	2003-07-03	2005-02-03	Bhatia Kuljit S.	Delivery system for topical medications
US7776355B2 (en) *	2003-07-03	2010-08-17	Medics Pharmaceutical Corporation	Delivery system for topical medications
US7479289B2 (en) *	2004-07-02	2009-01-20	Medicis Pharmaceutical Corporation	Stable cleanser compositions containing sulfur
US7655682B2 (en)	2004-07-02	2010-02-02	Medicis Pharmaceutical Corporation	Triple anti-irritant composition
KR20070115939A (ko) *	2005-03-10	2007-12-06	제이알 켐, 엘엘씨	벤조일 퍼옥사이드 조성물 및 이용 방법
JP5155849B2 (ja) *	2005-03-10	2013-03-06	ジェイアールケムエルエルシー	安定性有機過酸化物組成物
WO2007002880A2 (en) *	2005-06-29	2007-01-04	Jr Chem, Llc	Method of enhanced drug application
US20090306023A1 (en) *	2005-06-29	2009-12-10	Ramirez Jose E	Stable organic peroxide compositions
US7556820B2 (en)	2005-06-29	2009-07-07	Jr Chem, Llc	Stable organic peroxide compositions
WO2007005471A2 (en) *	2005-06-29	2007-01-11	Jr Chem, Llc	Stable organic peroxide compositions
ES2582654T3 (es)	2006-03-31	2016-09-14	Stiefel Research Australia Pty Ltd	Gel en suspensión espumable
CA2723029C (en)	2008-06-05	2016-07-19	Dow Pharmaceutical Sciences, Inc.	Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
FR2953832B1 (fr) *	2009-12-10	2012-01-13	Galderma Res & Dev	Derives de nouveaux peroxydes, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique pour le traitement ou la prevention de l'acne
CA2996095C (en) *	2015-08-28	2023-08-15	Akzo Nobel Chemicals International B.V.	Formulation for the treatment of acne
EP3405091B1 (de)	2016-01-19	2019-07-31	3M Innovative Properties Company	Verbraucherschrubbartikel mit schmutzlösung und verfahren zur herstellung davon
JP2023504422A (ja) *	2019-11-29	2023-02-03	ドゥムタ	ヒドロペルオキシアルコール及びその誘導体の抗微生物剤としての使用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3558665A (en) *	1966-03-03	1971-01-26	Argus Chem	Epoxidized peroxides
US3535422A (en) *	1968-03-11	1970-10-20	Stiefel Laboratories	Stable benzoyl peroxide composition

1986
- 1986-09-30 FR FR8613606A patent/FR2604435B1/fr not_active Expired
1987
- 1987-09-29 IT IT22072/87A patent/IT1222771B/it active
- 1987-09-29 CA CA000548168A patent/CA1282429C/fr not_active Expired - Lifetime
- 1987-09-29 CH CH3773/87A patent/CH672125A5/fr not_active IP Right Cessation
- 1987-09-29 NL NL8702320A patent/NL8702320A/nl not_active Application Discontinuation
- 1987-09-29 DE DE19873732839 patent/DE3732839A1/de not_active Withdrawn
- 1987-09-29 JP JP62245744A patent/JPS6391362A/ja active Pending
- 1987-09-29 US US07/102,492 patent/US4803228A/en not_active Expired - Fee Related
- 1987-09-30 GB GB8722933A patent/GB2196339B/en not_active Expired - Lifetime
- 1987-09-30 BE BE8701108A patent/BE1004154A4/fr not_active IP Right Cessation

Also Published As

Publication number	Publication date
CH672125A5 (de)	1989-10-31
FR2604435A1 (fr)	1988-04-01
GB2196339A (en)	1988-04-27
FR2604435B1 (fr)	1988-12-02
IT1222771B (it)	1990-09-12
CA1282429C (fr)	1991-04-02
GB8722933D0 (en)	1987-11-04
BE1004154A4 (fr)	1992-10-06
JPS6391362A (ja)	1988-04-22
US4803228A (en)	1989-02-07
DE3732839A1 (de)	1988-03-31
GB2196339B (en)	1990-04-25
IT8722072A0 (it)	1987-09-29

Publication	Publication Date	Title
NL8702320A (nl)	1988-04-18	Onverzadigde aromatische peroxiden en toepassing daarvan in de geneeskunde en de cosmetica.
NL8702321A (nl)	1988-04-18	Farmaceutische en cosmetische samenstelling voor de bestrijding van acne.
WO1986006064A1 (fr)	1986-10-23	Derives naphtaleniques a action de type retinoide, leur procede de preparation et compositions medicamenteuse et cosmetique les contenant
LU85789A1 (fr)	1986-09-02	Utilisation dans les domaines therapeutique et cosmetique d'une solution anhydre de peroxyde d'hydrogene
FR2689131A1 (fr)	1993-10-01	Procédé de préparation de monoesters majoritairement en position 6' du D-maltose et leur utilisation dans les domaines cosmétique, bucco-dentaire, pharmaceutique et alimentaire.
BE1001091A4 (fr)	1989-07-11	Nouveaux ethers de polyglycerols et leur utilisation en cosmetique et en pharmacie.
MC1525A1 (fr)	1984-04-13	Preparation d'une composition pour le traitement de la seborrhee
FR2649697A1 (fr)	1991-01-18	Nouveaux derives d'urethanne, leur preparation et leur application notamment comme agents hydratants dans des compositions cosmetiques ou pharmaceutiques destinees au traitement des peaux seches
FR2618068A1 (fr)	1989-01-20	Composition a base de derives d'hydroxypyridone pour diminuer la chute des cheveux
CH658189A5 (fr)	1986-10-31	Composition anti-acneique contenant en tant que compose actif un derive d'isothiazolo-(5,4b) pyridine one-3.
EP0597776B1 (de)	1998-01-14	4-Hydroxy-phenyl-beta-D-glukose-monoester, Verfahren zur ihrer Herstellung und ihre Verwendung in der Kosmetik, der Pharmazie, als Zahnpflegemitteln und Lebensmitteln
CA2003595A1 (fr)	1990-05-22	Utilisation de diorganopolysiloxanes comme anti-oxydants en cosmetique ou en dermatologie
LU87339A1 (fr)	1990-04-06	Nouveaux derives de benzylidene-cyclanones,leur procede de preparation,leur utilisation en tant qu'agents anti-oxydants et comme filtres solaires,compositions cosmetiques et pharmaceutiques les contenant
US4199599A (en)	1980-04-22	Glyceryl-tri-3,5,5-trimethylhexanoate protecting the skin therewith and cosmetic compositions therefore
EP0737508B1 (de)	1997-04-16	Verwendung einer Fluorkohlenwasserstoffverbindung in einer Emulsion, diese enthaltende Emulsion und Zusammensetzung
FR2580631A1 (fr)	1986-10-24	Hydroxy-1 acyloxy-8 acyl-10 anthrones, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique
CA1307467C (fr)	1992-09-15	Composition destinee au traitement de l'acne et de la seborrhee contenant en tant qu'agent actif un hydroperoxyde
EP0753341B1 (de)	1997-07-23	Verwendung von Fluorokohlwasserstoffthiolestern in Emulsionen, kosmetische oder dermatologische Anwendungen
CH670633A5 (de)	1989-06-30
FR2644459A1 (fr)	1990-09-21	Esters retinoiques de l-cladinose, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique
FR2696467A1 (fr)	1994-04-08	Procédé de préparation de monoesters d'acides gras du D-fructose et leur utilisation dans les domaines cosmétique, bucco-dentaire, pharmaceutique et alimentaire.
FR2483918A1 (fr)	1981-12-11	Composition anti-inflammatoire contenant a titre de principe actif des derives de l'acide phenyl-acetique ou phenyl-propionique
EP0004810B1 (de)	1986-04-23	Thenoylperoxyd als Arzneimittel sowie seine Verwendung als Kosmetikum, dieses enthaltende pharmazeutische und kosmetische Zusammensetzungen
FR2555450A1 (fr)	1985-05-31	Composition anti-acneique contenant en tant que compose actif un derive d'isothiazolo-(5,4b) pyridine one-3
JPH01163176A (ja)	1989-06-27	ビタミンｅパルミトレイン酸エステル及びその製造方法

Legal Events

Date	Code	Title	Description
1994-05-02	BV	The patent application has lapsed